Arg¹⁶ ADRB2 genotype increases the risk of exacerbations in children with a reported use of beta-2 agonists: Results of the PACMAN cohort study,Het genotype ADRB2 arg¹⁶ verhoogt de kans op astmaexacerbaties bij kinderen die langwerkende beta-2-agonisten gebruiken: Resultaten van de PACMAN-cohortstudie

Journal article published in 2015 by S. J. H. Vijverberg , M. J. L. Zuurhout, A. H. Maitland-Van Der Zee

This paper was not found in any repository; the policy of its publisher is unknown or unclear.

Full text: Unavailable

Preprint: policy unknown

Upload

Postprint: policy unknown

Upload

Published version: policy unknown

Upload